NewAmsterdam Pharma Company N.V. (NasdaqGM: NAMS)
Health Care · Biotechnology · NL
$21.26
-8.36% today · -28.6% 1Y
NewAmsterdam Pharma Company N.V. (NasdaqGM: NAMS) operates in the Biotechnology industry within the Health Care sector. The company is valued at $2.77B and employs 100 people.
Over the last twelve months the share price has lost 28.6%, trading between 21.02 and 42.21.
Tweenvest scores NewAmsterdam Pharma Company N.V. across four factors: quality 40/100, value 48/100. Its strongest factor is value.
NAMS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.77B
- Revenue (TTM)
- $7.12M
- P/E
- —
- EPS
- -2.14
- Dividend yield
- —
- Beta (5Y)
- 0.10
- 52-week high
- $42.21
- 52-week low
- $21.02
- Avg volume (3M)
- —
- Shares outstanding
- 119.54M
- Employees
- 100
- Next earnings
- —
About NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with cardiometabolic disease. It is developing Obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer’s disease. NewAmsterdam Pharma Company N.V. is headquartered in Naarden, the Netherlands.
- ISIN
- NL00150012L7
- Listed since
- Feb 9, 2021
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc.NasdaqGS: ARQT | $3.04B | $24.49 | +1.32% |
| Dyne Therapeutics, Inc.NasdaqGS: DYN | $2.98B | $16.37 | +2.50% |
| Keymed Biosciences Inc.SEHK: 2162 | $2.96B | HK$78.85 | +5.20% |
| Sino Biological,Inc.SZSE: 301047 | $2.88B | CN¥159.00 | +8.27% |
| Zai Lab LimitedNasdaqGM: ZLAB | $2.73B | $24.81 | +1.97% |
| Yili Chuanning Biotechnology Co.,Ltd.SZSE: 301301 | $2.73B | CN¥8.19 | +2.12% |
| BioArctic AB (publ)OM: BIOA B | $2.70B | Skr305.20 | -2.55% |
| BGI Genomics Co., Ltd.SZSE: 300676 | $2.62B | CN¥45.86 | +1.64% |
Figures last refreshed Oct 4, 2026.